AI brief of an SEC Form 8-K · Lumexa Imaging Holdings, Inc. (LMRI)

Lumexa Imaging Q2 revenue rises 5.1% to $264.2 million; net income $2.7 million

Positive Impact 3 of 5 earnings Written later

Lumexa Imaging reported second quarter 2026 revenue of $264.2 million, up 5.1% from a year earlier, and net income of $2.7 million, compared with a net loss of $7.2 million in the same quarter of 2025. The company reiterated its full-year 2026 revenue guidance and narrowed its Adjusted EBITDA range to $235 million to $241 million, leaving the midpoint at $238 million.

Key points

  • Q2 2026 revenue of $264.2 million vs. $251.4 million; system-wide revenue growth of 6.0%
  • Net income of $2.7 million, or $0.03 per diluted share, vs. a net loss of $7.2 million a year earlier
  • Adjusted EBITDA of $56.4 million vs. $56.3 million; Adjusted EBITDA margin fell to 21.4% from 22.4%
  • Full-year 2026 guidance: revenue $1.045 billion to $1.097 billion (reiterated); Adjusted EPS $0.71 to $0.77 (reiterated)

The filing

CompanyLumexa Imaging Holdings, Inc. (LMRI)
Form8-K, current report
Filed with the SECAug 12, 2026, 4:05 PM ET
Accession number0001193125-26-346813

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.